Sernova (SVA) Competitors C$0.25 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades SVA vs. PLI, ABCN, EMC, MDNA, BCT, FRX, IPA, ONC, SCYB, and COMShould you be buying Sernova stock or one of its competitors? The main competitors of Sernova include ProMetic Life Sciences (PLI), VIVO Cannabis (ABCN), Emblem (EMC), Medicenna Therapeutics (MDNA), BriaCell Therapeutics (BCT), Fennec Pharmaceuticals (FRX), ImmunoPrecise Antibodies (IPA), Oncolytics Biotech (ONC), Scythian Biosciences (SCYB), and 138267 (COM.TO) (COM). These companies are all part of the "biotechnology" industry. Sernova vs. ProMetic Life Sciences VIVO Cannabis Emblem Medicenna Therapeutics BriaCell Therapeutics Fennec Pharmaceuticals ImmunoPrecise Antibodies Oncolytics Biotech Scythian Biosciences 138267 (COM.TO) Sernova (TSE:SVA) and ProMetic Life Sciences (TSE:PLI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk. Does the media refer more to SVA or PLI? In the previous week, Sernova had 1 more articles in the media than ProMetic Life Sciences. MarketBeat recorded 1 mentions for Sernova and 0 mentions for ProMetic Life Sciences. Sernova's average media sentiment score of 0.00 equaled ProMetic Life Sciences'average media sentiment score. Company Overall Sentiment Sernova Neutral ProMetic Life Sciences Neutral Is SVA or PLI more profitable? ProMetic Life Sciences' return on equity of 0.00% beat Sernova's return on equity.Company Net Margins Return on Equity Return on Assets SernovaN/A -726.29% -119.26% ProMetic Life Sciences N/A N/A N/A Does the MarketBeat Community favor SVA or PLI? ProMetic Life Sciences received 431 more outperform votes than Sernova when rated by MarketBeat users. However, 91.67% of users gave Sernova an outperform vote while only 67.69% of users gave ProMetic Life Sciences an outperform vote. CompanyUnderperformOutperformSernovaOutperform Votes1191.67% Underperform Votes18.33%ProMetic Life SciencesOutperform Votes44267.69% Underperform Votes21132.31% Which has stronger valuation & earnings, SVA or PLI? Sernova has higher earnings, but lower revenue than ProMetic Life Sciences. Sernova is trading at a lower price-to-earnings ratio than ProMetic Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSernovaN/AN/A-C$38.93M-C$0.13-1.92ProMetic Life SciencesC$39.91M7.94-C$1.47B-C$63.06-0.22 Do analysts recommend SVA or PLI? Sernova presently has a consensus price target of C$1.83, suggesting a potential upside of 633.33%. Given Sernova's higher possible upside, analysts clearly believe Sernova is more favorable than ProMetic Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sernova 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00ProMetic Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Do institutionals & insiders believe in SVA or PLI? 0.1% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummarySernova beats ProMetic Life Sciences on 9 of the 14 factors compared between the two stocks. Ad Investing Daily626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trader has done over the past 8 years—closing 647 trades, with an unbelievable 97% win rate. Now, for the first time, he's breaking his silence and revealing his personal technique for success.Click here to watch our exclusive interview and uncover his personal technique Get Sernova News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SVA vs. The Competition Export to ExcelMetricSernovaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$81.33MC$181.83MC$5.20BC$4.84BDividend Yield7.86%3.48%7.52%6.57%P/E Ratio-1.92345.0099.3726.36Price / SalesN/A20,068.741,664.501,326.94Price / Cash6.1511.2437.5373.11Price / Book-6.256.894.743.17Net Income-C$38.93M-C$19.41MC$116.38MC$271.84M7 Day Performance4.17%0.52%-0.82%0.16%1 Month Performance-3.85%2.08%5.49%1.53%1 Year Performance-68.75%23.04%34.03%41.42% Sernova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SVASernova2.0104 of 5 starsC$0.25flatC$1.83+633.3%-68.8%C$81.33MN/A-1.921,959Gap UpPLIProMetic Life SciencesN/AC$13.60+0.2%N/AN/AC$317.06MC$39.91M-0.22487ABCNVIVO CannabisN/AC$1.32+5.6%N/A+0.0%C$256.62MN/A0.00N/ANews CoverageNegative NewsGap UpEMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AMDNAMedicenna TherapeuticsN/AC$2.37-5.6%N/A+587.0%C$181.14MN/A-6.2420BCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195FRXFennec PharmaceuticalsN/AC$6.08flatN/A-34.8%C$166.35MC$48.89M60.8010Upcoming EarningsIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownONCOncolytics Biotech1.3865 of 5 starsC$1.60-3.6%C$3.50+118.8%-31.9%C$122.98MN/A-4.2129SCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/A Related Companies and Tools Related Companies ProMetic Life Sciences Alternatives VIVO Cannabis Alternatives Emblem Alternatives Medicenna Therapeutics Alternatives BriaCell Therapeutics Alternatives Fennec Pharmaceuticals Alternatives ImmunoPrecise Antibodies Alternatives Oncolytics Biotech Alternatives Scythian Biosciences Alternatives 138267 (COM.TO) Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:SVA) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SVA Stock Alerts